Clinical trial

Onsite Buprenorphine Treatment at Syringe Exchange Programs

NCT03150173

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-01-02

PhasePHASE2

Study timeline

Study start (actual)2019-01-02Date precision: day

Registry last updated2025-12-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Opiate Addictionunresolved

Interventions

Onsite treatmentBEHAVIORAL

Enhanced referralBEHAVIORAL

BuprenorphineDRUG

Sponsors & collaborators

Montefiore Medical Centerlead sponsor

National Institute on Drug Abuse (NIDA)collaborator

Mapped research locations

New YorkNew York, United States2 The BronxNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03150173 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.